Biomarkers and Genomic Testing
Tools You Can Use
Liquid Biopsy/ctDNA Testing: Signatera
Liquid Biopsy/ctDNA (for MRD) Testing: Guardant Reveal
Liquid Biopsy/ctDNA Testing: Guardant360®
Tissue Testing: Immunoscore®
Questions? Feedback?

Additional Immunoscore® resources

This presentation, sponsored by Digestive Cancers Europe, provides an overview of the role of patient’s immune response in early colorectal cancer and the best approach for patients and doctors to jointly manage treatment at this stage for improved patient outcomes. Dr. Dhillon is a medical oncologist based at The Royal Surrey Hospital NHS in the UK.

Recent scientific publications about Immunoscore:

International validation of the consensus Immunoscore, Lancet 2018

Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer, JNCI 2020

Prognostic & Predictive value of the Immunoscore in Stage III Colon Cancer, Annals of Oncology 2020

For more information, please contact:

Veracyte Labs VA

737 N 5th St, Suite 600, Richmond, VA, 23219


[email protected]